CN113667653B - Transdermal total-absorption anti-aging nano-functional mask based on superoxide dismutase - Google Patents
Transdermal total-absorption anti-aging nano-functional mask based on superoxide dismutase Download PDFInfo
- Publication number
- CN113667653B CN113667653B CN202110993092.8A CN202110993092A CN113667653B CN 113667653 B CN113667653 B CN 113667653B CN 202110993092 A CN202110993092 A CN 202110993092A CN 113667653 B CN113667653 B CN 113667653B
- Authority
- CN
- China
- Prior art keywords
- mutant
- sod
- mask
- sod enzyme
- aging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 11
- 102000019197 Superoxide Dismutase Human genes 0.000 title abstract description 8
- 108010012715 Superoxide dismutase Proteins 0.000 title abstract description 8
- 238000010521 absorption reaction Methods 0.000 title abstract description 4
- 102000004190 Enzymes Human genes 0.000 claims description 34
- 108090000790 Enzymes Proteins 0.000 claims description 34
- 229910052802 copper Inorganic materials 0.000 claims description 26
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- 239000002537 cosmetic Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- 210000002966 serum Anatomy 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 3
- 239000004202 carbamide Substances 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 229920002674 hyaluronan Polymers 0.000 claims description 3
- 229960003160 hyaluronic acid Drugs 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 238000002791 soaking Methods 0.000 claims 1
- 230000009759 skin aging Effects 0.000 abstract description 3
- 230000037303 wrinkles Effects 0.000 abstract 1
- 102220489765 Cofilin-1_H47A_mutation Human genes 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 238000012360 testing method Methods 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 7
- 230000035772 mutation Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 102220484419 Myb/SANT-like DNA-binding domain-containing protein 1_S39G_mutation Human genes 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- -1 lipid peroxide Chemical class 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 3
- 230000002292 Radical scavenging effect Effects 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 230000037394 skin elasticity Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- MQIGTEQXYCRLGK-BQBZGAKWSA-N Ala-Gly-Pro Chemical compound C[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O MQIGTEQXYCRLGK-BQBZGAKWSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- NWVVKQZOVSTDBQ-CIUDSAMLSA-N Ala-Glu-Arg Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NWVVKQZOVSTDBQ-CIUDSAMLSA-N 0.000 description 1
- NHLAEBFGWPXFGI-WHFBIAKZSA-N Ala-Gly-Asn Chemical compound C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)O)N NHLAEBFGWPXFGI-WHFBIAKZSA-N 0.000 description 1
- WMYJZJRILUVVRG-WDSKDSINSA-N Ala-Gly-Gln Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O WMYJZJRILUVVRG-WDSKDSINSA-N 0.000 description 1
- FFZJHQODAYHGPO-KZVJFYERSA-N Ala-Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N FFZJHQODAYHGPO-KZVJFYERSA-N 0.000 description 1
- MSWSRLGNLKHDEI-ACZMJKKPSA-N Ala-Ser-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O MSWSRLGNLKHDEI-ACZMJKKPSA-N 0.000 description 1
- 101000836247 Aquifex pyrophilus Superoxide dismutase [Fe] Proteins 0.000 description 1
- OQPAZKMGCWPERI-GUBZILKMSA-N Arg-Ser-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O OQPAZKMGCWPERI-GUBZILKMSA-N 0.000 description 1
- OOWSBIOUKIUWLO-RCOVLWMOSA-N Asn-Gly-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O OOWSBIOUKIUWLO-RCOVLWMOSA-N 0.000 description 1
- LMIWYCWRJVMAIQ-NHCYSSNCSA-N Asn-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N LMIWYCWRJVMAIQ-NHCYSSNCSA-N 0.000 description 1
- SBHUBSDEZQFJHJ-CIUDSAMLSA-N Asp-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O SBHUBSDEZQFJHJ-CIUDSAMLSA-N 0.000 description 1
- YDJVIBMKAMQPPP-LAEOZQHASA-N Asp-Glu-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O YDJVIBMKAMQPPP-LAEOZQHASA-N 0.000 description 1
- RNAQPBOOJRDICC-BPUTZDHNSA-N Asp-Met-Trp Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC(=O)O)N RNAQPBOOJRDICC-BPUTZDHNSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- LPBUBIHAVKXUOT-FXQIFTODSA-N Cys-Val-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CS)N LPBUBIHAVKXUOT-FXQIFTODSA-N 0.000 description 1
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- KQDMENMTYNBWMR-WHFBIAKZSA-N Gly-Asp-Ala Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O KQDMENMTYNBWMR-WHFBIAKZSA-N 0.000 description 1
- LHYJCVCQPWRMKZ-WEDXCCLWSA-N Gly-Leu-Thr Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LHYJCVCQPWRMKZ-WEDXCCLWSA-N 0.000 description 1
- WMGHDYWNHNLGBV-ONGXEEELSA-N Gly-Phe-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 WMGHDYWNHNLGBV-ONGXEEELSA-N 0.000 description 1
- GLACUWHUYFBSPJ-FJXKBIBVSA-N Gly-Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN GLACUWHUYFBSPJ-FJXKBIBVSA-N 0.000 description 1
- ZVXMEWXHFBYJPI-LSJOCFKGSA-N Gly-Val-Ile Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ZVXMEWXHFBYJPI-LSJOCFKGSA-N 0.000 description 1
- WEIYKCOEVBUJQC-JYJNAYRXSA-N His-Glu-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC2=CN=CN2)N WEIYKCOEVBUJQC-JYJNAYRXSA-N 0.000 description 1
- CGAMSLMBYJHMDY-ONGXEEELSA-N His-Val-Gly Chemical compound CC(C)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC1=CN=CN1)N CGAMSLMBYJHMDY-ONGXEEELSA-N 0.000 description 1
- 208000002979 Influenza in Birds Diseases 0.000 description 1
- GPJGFSFYBJGYRX-YUMQZZPRSA-N Lys-Gly-Asp Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O GPJGFSFYBJGYRX-YUMQZZPRSA-N 0.000 description 1
- FHIAJWBDZVHLAH-YUMQZZPRSA-N Lys-Gly-Ser Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O FHIAJWBDZVHLAH-YUMQZZPRSA-N 0.000 description 1
- WVJNGSFKBKOKRV-AJNGGQMLSA-N Lys-Leu-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WVJNGSFKBKOKRV-AJNGGQMLSA-N 0.000 description 1
- WGXOKDLDIWSOCV-MELADBBJSA-N Phe-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O WGXOKDLDIWSOCV-MELADBBJSA-N 0.000 description 1
- CDQCFGOQNYOICK-IHRRRGAJSA-N Phe-Glu-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 CDQCFGOQNYOICK-IHRRRGAJSA-N 0.000 description 1
- OQTDZEJJWWAGJT-KKUMJFAQSA-N Phe-Lys-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O OQTDZEJJWWAGJT-KKUMJFAQSA-N 0.000 description 1
- PEFJUUYFEGBXFA-BZSNNMDCSA-N Phe-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=CC=C1 PEFJUUYFEGBXFA-BZSNNMDCSA-N 0.000 description 1
- ALJGSKMBIUEJOB-FXQIFTODSA-N Pro-Ala-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@@H]1CCCN1 ALJGSKMBIUEJOB-FXQIFTODSA-N 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- UFKPDBLKLOBMRH-XHNCKOQMSA-N Ser-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)N)C(=O)O UFKPDBLKLOBMRH-XHNCKOQMSA-N 0.000 description 1
- HEUVHBXOVZONPU-BJDJZHNGSA-N Ser-Leu-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HEUVHBXOVZONPU-BJDJZHNGSA-N 0.000 description 1
- UBRMZSHOOIVJPW-SRVKXCTJSA-N Ser-Leu-Lys Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O UBRMZSHOOIVJPW-SRVKXCTJSA-N 0.000 description 1
- JLKWJWPDXPKKHI-FXQIFTODSA-N Ser-Pro-Asn Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CO)N)C(=O)N[C@@H](CC(=O)N)C(=O)O JLKWJWPDXPKKHI-FXQIFTODSA-N 0.000 description 1
- TZKPNGDGUVREEB-FOHZUACHSA-N Thr-Asn-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O TZKPNGDGUVREEB-FOHZUACHSA-N 0.000 description 1
- YBXMGKCLOPDEKA-NUMRIWBASA-N Thr-Asp-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O YBXMGKCLOPDEKA-NUMRIWBASA-N 0.000 description 1
- UDQBCBUXAQIZAK-GLLZPBPUSA-N Thr-Glu-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O UDQBCBUXAQIZAK-GLLZPBPUSA-N 0.000 description 1
- XFTYVCHLARBHBQ-FOHZUACHSA-N Thr-Gly-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O XFTYVCHLARBHBQ-FOHZUACHSA-N 0.000 description 1
- FDALPRWYVKJCLL-PMVVWTBXSA-N Thr-His-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)NCC(O)=O FDALPRWYVKJCLL-PMVVWTBXSA-N 0.000 description 1
- LECUEEHKUFYOOV-ZJDVBMNYSA-N Thr-Thr-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)[C@@H](C)O LECUEEHKUFYOOV-ZJDVBMNYSA-N 0.000 description 1
- IMXAAEFAIBRCQF-SIUGBPQLSA-N Tyr-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N IMXAAEFAIBRCQF-SIUGBPQLSA-N 0.000 description 1
- KNYHAWKHFQRYOX-PYJNHQTQSA-N Val-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](C(C)C)N KNYHAWKHFQRYOX-PYJNHQTQSA-N 0.000 description 1
- AEFJNECXZCODJM-UWVGGRQHSA-N Val-Val-Gly Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](C(C)C)C(=O)NCC([O-])=O AEFJNECXZCODJM-UWVGGRQHSA-N 0.000 description 1
- AOILQMZPNLUXCM-AVGNSLFASA-N Val-Val-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN AOILQMZPNLUXCM-AVGNSLFASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 108010016616 cysteinylglycine Proteins 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000007323 disproportionation reaction Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- JYPCXBJRLBHWME-UHFFFAOYSA-N glycyl-L-prolyl-L-arginine Natural products NCC(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(O)=O JYPCXBJRLBHWME-UHFFFAOYSA-N 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 108010040030 histidinoalanine Proteins 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000007852 inverse PCR Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y115/00—Oxidoreductases acting on superoxide as acceptor (1.15)
- C12Y115/01—Oxidoreductases acting on superoxide as acceptor (1.15) with NAD or NADP as acceptor (1.15.1)
- C12Y115/01001—Superoxide dismutase (1.15.1.1)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The invention provides a novel superoxide dismutase mutant, which shows the purposes of improving skin aging and reducing wrinkles and has wide application prospect. Furthermore, the invention also provides a transdermal total-absorption anti-aging nano-functional mask containing the mutant.
Description
Technical Field
The invention belongs to the field of biological enzymes, and particularly relates to mutant superoxide dismutase and a transdermal total-absorption anti-aging nano functional mask based on the superoxide dismutase.
Background
Two main causes of skin aging are due to sunlight irradiation and the invasion of active oxygen. The active oxygen removes foreign substances by decomposing the foreign substances during the removal of the foreign substances entering the body. However, while playing a positive role, if excessive active oxygen is generated for various reasons, it not only invades the own cell tissues but also combines with unsaturated fatty acids in the body to form lipid peroxide. In particular, the skin is aged by being combined with proteins and lipids to form oxides, and the oxides have a strong effect on the oxidation process of melanin to cause pigmentation.
Superoxide dismutase (Superoxide Dismutase, SOD) is an antioxidant metalloenzyme existing in organisms, can catalyze superoxide anion free radical disproportionation to generate oxygen and hydrogen peroxide, and plays a vital role in organism oxidation and antioxidant balance. Depending on the metal prosthetic groups contained in SOD, it can be generally classified into Cu, zn-SOD, mn-SOD and Fe-SOD. The supplement of exogenous SOD has the functions of delaying skin aging, resisting oxidation and removing color spots, and can be widely added into various cosmetics or skin care products.
Since the eighties of the last century, the research on the application of SOD has been mainly focused on the extraction and purification of animal and plant SOD, most of domestic SOD products are prepared from animal blood, but due to the limited raw materials and the health safety, the product yield is limited, especially as the risk of malignant infectious diseases such as mad cow disease, avian influenza, foot-and-mouth disease and the like in the world is reported from time to time, the increase of the purity requirement also increases the cost of the product, especially due to the influence of mad cow disease, the EU prescribes that after the use of bovine blood SOD as a food additive is forbidden from 1 month in 1997, the utilization of genetic engineering is an effective way for widely opening SOD enzyme sources, reducing the cost and obtaining SOD with natural activity. However, SOD enzymes have problems of low genetic engineering yield, unstable activity and the like, and when applied to cosmetics, the SOD enzymes need to be increased in stability against a wider range of temperatures so as to facilitate transportation, so that development of SOD enzymes capable of overcoming the adverse factors is very necessary.
Disclosure of Invention
To solve the above technical problems, a first aspect of the present application provides a mutant Cu, zn-SOD enzyme. More specifically, the amino acid sequence of the mutant Cu, zn-SOD enzyme is shown as SEQ ID NO. 1.
In a second aspect of the present application, there is provided the use of a mutated Cu, zn-SOD enzyme for the preparation of an anti-ageing cosmetic, preferably a cosmetic which is a serum or a mask, more preferably a serum comprising the following components in mass percent:
the mutant Cu, zn and SOD enzyme is 2-5%, glycerin is 5-8%, hyaluronic acid is 0.01-2%, L-vitamin C is 0.01-2%, vitamin E is 2-5%, urea is 1-2%, propylene glycol is 0.5-2%, and the balance is deionized water.
In a third aspect of the present application, an anti-aging mask containing the mutated Cu, zn-SOD enzyme is provided, and the preparation method of the mask is to soak the mask material with the essence or add the essence into the mask material. More preferably, the facial mask is a nano facial mask.
Compared with the prior art, the invention has the following advantages:
1) According to the invention, the double mutation Cu, zn-SOD enzyme of H47A, G86W is obtained by carrying out amino acid mutation on the Cu, zn-SOD enzyme (NP-012638.1) of Saccharomyces cerevisiae (Saccharomyces cerevisiae), so that the thermal stability is obviously improved under the condition of keeping the activity, and the method has wide application value and economic value;
2) The invention ferments and produces the mutant Cu, zn-SOD enzyme by genetic engineering technology, and prepares the mutant Cu, zn-SOD enzyme into skin care products such as essence, mask and the like, and the products can restore the skin to a flexible young state and have obvious anti-aging effect.
Drawings
Comparison of enzyme Activity of the mutants of FIG. 1 before and after Heat treatment
Detailed Description
Example 1: mutant enzyme thermostability
The 4 key amino acid sites (S39G, H47A, G86W, H131Q) from Saccharomyces cerevisiae (Saccharomyces cerevisiae) Cu, zn-SOD enzyme (NP 012638.1) were selected for mutation engineering studies from NCBI.
And constructing Cu, zn-SOD enzyme site-directed transformation mutants by a one-step inverse PCR method, and transforming the correctly constructed site-directed mutation transformation plasmid into host cells after sequencing verification.
The recombinant bacteria of each mutation site (group 1: S39G+H47A, group 2: S39G+G86W, group 3: S39G+H131Q, group 4: H47A+G86W, group 5: H47A+H131Q and group 6: G86W+H131Q) which are constructed correctly are subjected to streaking to separate single colonies, the single colonies are picked up to an LB culture medium (Kan) for culturing for 12 hours, inoculated to a TB fermentation culture medium (Kan) for fermentation culturing for 26 hours, and fermentation supernatants, namely, the mutant recombinases, are subjected to water bath heat preservation at a temperature of pH7.0 and a temperature of 60 ℃ for 15 minutes, and enzyme activities before and after heat treatment are detected respectively. The original enzyme activity which was not mutated and which was not heat-treated at 60℃was taken as 100% (control group). As shown in FIG. 1, the residual enzyme activity of the S39G+H243 47A, H47A+G86W mutant was higher than that of the control bacterium after heat treatment. The h47a+g86W mutant showed a significant increase in thermostability.
Example 2: verification of antioxidant Activity
Test sample: the wild Cu, zn-SOD enzyme and H47A+G86W double mutation Cu, zn-SOD enzyme are respectively mixed with ultrapure water to be diluted into a test solution with the mass fraction of 5 percent.
Hydroxyl radical scavenging experiments: the absorbance values of each group of mixed solutions were measured at 536nm using spectrophotometry conventional in the art, and were recorded As, the absorbance values were measured with distilled water instead of the sample solution As a blank group, as Ab, and distilled water instead of H 2 O 2 As a damage group, its absorbance value An was measured, and the hydroxyl radical clearance of the test sample was calculated according to the following formula: hydroxyl radical clearance (%) = [ (As-An)/(Ab-An)]X 100% and taking the average of three measurements. The test results are shown in Table 1.
DPPH radical scavenging experiment: taking 3mL of DPPH-absolute ethyl alcohol solution with the concentration of 0.2mmol/L in a cuvette, adding 1mL of test sample, mixing uniformly, keeping away from light at room temperature for 30min, measuring absorbance at 517nm wavelength, marking the absorbance value as A1, adding 3mL of absolute ethyl alcohol solution and 1mL of test sample solution, marking the absorbance value as A2, and adding 3mL of DPPH-absolute ethyl alcohol solution and 1mL of absolute ethyl alcohol solution, marking the absorbance value as A3. DPPH radical scavenging was calculated as follows: DPPH radical clearance (%) = [1- (A1-A2)/A3 ] ×100%, the average of three measurements was taken. The test results are shown in Table 1.
TABLE 1
From the experimental results in Table 1, the H47A+G86W double mutant Cu, zn-SOD enzyme has improved hydroxy free radical clearance and DPPH free radical clearance compared with wild type, which shows that the mutant Cu, zn-SOD enzyme with improved thermal stability can effectively remove free radicals and has the effects of oxidation resistance and aging resistance.
EXAMPLE 3 skin elasticity and moisturizing Performance test of mutant preparations
The H47A+G86W double-mutation Cu, zn-SOD enzyme is prepared into skin care essence, and the skin care essence comprises the following components in percentage by mass:
h47a+g168w double mutation Cu, zn-sodase 5%, glycerol 5%, hyaluronic acid 1.5%, l-vitamin C1%, vitamin E5%, urea 1%, propylene glycol 0.5%, and the balance deionized water.
Control group 1 was a double mutant Cu, zn-SOD enzyme with H47A+G86W, replaced with wild Cu, zn-SOD enzyme.
Control group 2 was not added with Cu, zn-SOD enzyme.
Test population: 60 healthy volunteers with an average age of 40.+ -.2 were selected and randomly divided into three groups of 20 persons each, each of which was applied earlier than the face, and the subjects were not able to apply any other cosmetics at the experimental site during the experiment.
The testing method comprises the following steps:
the change in skin moisture content was tested using a moisture tester (corneometer cm 825) to evaluate the degree of moisture retention of the skin by the three samples; the change in skin elasticity value was measured with a skin elasticity tester (Cutometer dual MPA, 580). The results are shown in Table 2 below (average of three measurements):
TABLE 2
It will be apparent to those skilled in the art that various modifications and variations can be made to the present invention without departing from the spirit or scope of the invention. Thus, it is intended that the present invention also include such modifications and alterations insofar as they come within the scope of the appended claims or the equivalents thereof.
SEQUENCE LISTING
<110> Shenzhen City not two Biotech Co., ltd
<120> a mutant superoxide dismutase and use thereof in the preparation of anti-aging products
<130> 1
<160> 1
<170> PatentIn version 3.5
<210> 1
<211> 154
<212> PRT
<213> artificial sequence
<400> 1
Met Val Gln Ala Val Ala Val Leu Lys Gly Asp Ala Gly Val Ser Gly
1 5 10 15
Val Val Lys Phe Glu Gln Ala Ser Glu Ser Glu Pro Thr Thr Val Ser
20 25 30
Tyr Glu Ile Ala Gly Asn Ser Pro Asn Ala Glu Arg Gly Phe Ala Ile
35 40 45
His Glu Phe Gly Asp Ala Thr Asn Gly Cys Val Ser Ala Gly Pro His
50 55 60
Phe Asn Pro Phe Lys Lys Thr His Gly Ala Pro Thr Asp Glu Val Arg
65 70 75 80
His Val Gly Asp Met Trp Asn Val Lys Thr Asp Glu Asn Gly Val Ala
85 90 95
Lys Gly Ser Phe Lys Asp Ser Leu Ile Lys Leu Ile Gly Pro Thr Ser
100 105 110
Val Val Gly Arg Ser Val Val Ile His Ala Gly Gln Asp Asp Leu Gly
115 120 125
Lys Gly Asp Thr Glu Glu Ser Leu Lys Thr Gly Asn Ala Gly Pro Arg
130 135 140
Pro Ala Cys Gly Val Ile Gly Leu Thr Asn
145 150
Claims (7)
1. A mutant Cu, zn-SOD enzyme, wherein the amino acid sequence of the mutant Cu, zn-SOD enzyme is shown as SEQ ID NO. 1.
2. Use of a mutated Cu, zn-SOD enzyme according to claim 1 for the preparation of anti-ageing cosmetics.
3. The use according to claim 2, wherein the cosmetic product is a serum or a mask.
4. The use according to claim 3, wherein the serum comprises the following components in percentage by mass:
the mutant Cu, zn-SOD enzyme of claim 1 2-5%, glycerol 5-8%, hyaluronic acid 0.01-2%, l-vitamin C0.01-2%, vitamin E2-5%, urea 1-2%, propylene glycol 0.5-2%, the balance deionized water.
5. The use according to claim 3, wherein the mask is prepared by soaking the mask material with the essence of claim 4 or adding the essence to the mask material.
6. An anti-aging product, wherein the product is a serum or a mask, and the active ingredient of the product comprises the mutated Cu, zn-SOD enzyme of claim 1.
7. The anti-aging product of claim 6, wherein the product is a nano-mask.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2021109776516 | 2021-08-24 | ||
CN202110977651 | 2021-08-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113667653A CN113667653A (en) | 2021-11-19 |
CN113667653B true CN113667653B (en) | 2024-01-05 |
Family
ID=78546736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110993092.8A Active CN113667653B (en) | 2021-08-24 | 2021-08-27 | Transdermal total-absorption anti-aging nano-functional mask based on superoxide dismutase |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113667653B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6033889A (en) * | 1997-01-16 | 2000-03-07 | Korea Institute Of Science And Technology | Gene sequence of Aquifex pyrophilus superoxide dismutase and protein expressed in Escherichia coli |
CN101512001A (en) * | 2006-07-14 | 2009-08-19 | 诺维信股份有限公司 | Methods for increasing expression of genes in a fungal cell |
CN106619175A (en) * | 2016-11-10 | 2017-05-10 | 陕西慧康生物科技有限责任公司 | Genetic recombination superoxide dismutase mask |
-
2021
- 2021-08-27 CN CN202110993092.8A patent/CN113667653B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6033889A (en) * | 1997-01-16 | 2000-03-07 | Korea Institute Of Science And Technology | Gene sequence of Aquifex pyrophilus superoxide dismutase and protein expressed in Escherichia coli |
CN101512001A (en) * | 2006-07-14 | 2009-08-19 | 诺维信股份有限公司 | Methods for increasing expression of genes in a fungal cell |
CN106619175A (en) * | 2016-11-10 | 2017-05-10 | 陕西慧康生物科技有限责任公司 | Genetic recombination superoxide dismutase mask |
Non-Patent Citations (2)
Title |
---|
Goffeau,A ET AL.NP_012638.1.《NCBI》.2021,全文. * |
Presence of Cu/Zn superoxide dismutase (SOD) immunoreactivity in neuronal hyaline inclusions in spinal cords from mice carrying a transgene for Gly93Ala mutant human Cu/Zn SOD;N Shibata;《Acta Neuropathol》;第95卷(第2期);全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN113667653A (en) | 2021-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2019189596A (en) | Application of thermus thermophilus and yeast combined fermentation product | |
CN112043621B (en) | Preservative-free polypeptide composition with anti-aging effect | |
JP2019187409A (en) | Thermus thermophilus and yeast combined fermentation method | |
EP1301078B1 (en) | Peroxide treated yeast extract and method of production | |
CN111603434B (en) | Composition for improving skin wrinkles and cosmetic thereof | |
CN115054530B (en) | Skin care composition with moisturizing and anti-aging effects and preparation method thereof | |
KR20190056176A (en) | Cosmetic comoposition for anti-wrinkle comprising Lactobacillus plantarum culture | |
CN111150701A (en) | Anti-wrinkle firming essence and preparation method thereof | |
CN113667653B (en) | Transdermal total-absorption anti-aging nano-functional mask based on superoxide dismutase | |
CN113786378A (en) | Toning lotion composition with effects of improving skin color and brightening skin and preparation method thereof | |
CN109077971B (en) | A kind of preparation method of fermented soybean milk and its application in cosmetics | |
CN115634163B (en) | Whitening skin care essence emulsion and preparation method thereof | |
KR20200054590A (en) | Composition for improving skin barrier comprising precipitation of fermented rice bran as active ingredient | |
CN114796087A (en) | Preparation method of hypecoum maritimum stem cell extract and application of hypecoum maritimum stem cell extract in cosmetics | |
CN108888573B (en) | Soothing and moisturizing cream and preparation method thereof | |
KR20130099277A (en) | A cosmetic composition comprising hydrolysates of ecklonia cava | |
KR102482157B1 (en) | Cosmetic composition comprising the mixed culture broth of lactobacilli containing sulfur amino acids for skin stress improvement | |
CN111329830A (en) | Method for obtaining micrococcus bacterial fermentation cytolysis liquid and application of micrococcus bacterial fermentation cytolysis liquid in anti-aging | |
KR101289062B1 (en) | Cosmetic composition comprising growth factor and cytokine induced human placenta | |
CN115844771B (en) | Hot spring water fermentation product, repairing and anti-aging composition, and preparation method and application thereof | |
CN115844804B (en) | Composition for improving exogenous aging and preparation method and application thereof | |
KR102659073B1 (en) | Composition for improving skin condition comprising a strain expressing human collagen type 6 | |
KR101658799B1 (en) | Cosmetic composition having skin-lightening effect containing Natural component and the Fermented extract of horse placenta | |
CN115595276B (en) | Moisturizing and whitening cosmetic and preparation method thereof | |
CN110292538B (en) | Composition and application thereof in preparation of whitening and anti-aging cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20231204 Address after: Room 1304, No. 152 Huangbian North Road, Helong Street, Baiyun District, Guangzhou City, Guangdong Province, 510000 Applicant after: Guangzhou Wanqian vermicelli Cosmetics Co.,Ltd. Address before: 518000 32b3, building 2, building 1, Dachong Business Center (phase II), No. 9678, Shennan Avenue, Dachong community, Yuehai street, Nanshan District, Shenzhen, Guangdong Applicant before: Shenzhen Buer Biotechnology Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |